WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

IkerChem S.L. - Product Pipeline Review - Q4 2010

GlobalData, November 2010, Pages: 24

IkerChem S.L. – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “IkerChem S.L. - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- IkerChem S.L. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of IkerChem S.L. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of IkerChem S.L. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the IkerChem S.L.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate IkerChem S.L.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of IkerChem S.L. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the IkerChem S.L.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with IkerChem S.L..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of IkerChem S.L. and identify potential opportunities in those areas.



List of Tables
List of Figures
IkerChem S.L. Snapshot
IkerChem S.L. Overview
Key Information
Key Facts
IkerChem S.L. – Research and Development Overview
Key Therapeutic Areas
IkerChem S.L. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
IkerChem S.L. – Pipeline Products Glance
IkerChem S.L.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
IkerChem S.L. – Drug Profiles
IKH02
Product Description
Mechanism of Action
R&D Progress
IKH25
Product Description
Mechanism of Action
R&D Progress
DNMT Programme
Product Description
Mechanism of Action
R&D Progress
JMJ2DC(GASC1) Inhibitor Program
Product Description
Mechanism of Action
R&D Progress
Nano
Product Description
Mechanism of Action
R&D Progress
SIRT
Product Description
Mechanism of Action
R&D Progress
IkerChem S.L. – Pipeline Analysis
IkerChem S.L. – Pipeline Products by Therapeutic Class
IkerChem S.L. Pipeline Products By Target
IkerChem S.L. – Pipeline Products by Molecule Type
IkerChem S.L. – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought